FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150218241> ?p ?o ?g. }

• W3150218241 abstract "Background Patients with atopic dermatitis (AD) exhibit phenotypic variability in ethnicity and IgE status. In addition, some patients develop other allergic conditions, such as allergic rhinitis (AR), in subsequent life. Understanding the heterogeneity of AD would be beneficial to phenotype-specific therapies. Methods Twenty-eight Chinese AD patients and 8 healthy volunteers were enrolled in the study. High-throughput transcriptome sequencing was conducted on lesional and nonlesional skin samples from 10 AD patients and matched normal skin samples from 5 healthy volunteers. Identification of differentially expressed genes (DEGs), KEGG pathway analyses, and sample cluster analyses were conducted in the R software environment using the DEseq2, ClusterProfiler, and pheatmap R packages, respectively. qRT-PCR, Western blotting, and ELISA were used to detect gene expression levels among subtypes. Correlation analysis was performed to further investigate their correlation with disease severity. Results A total of 25,798 genes were detected per sample. Subgroup differential expression analysis and functional enrichment analysis revealed significant changes in the IL17 signaling pathway in Chinese EAD patients but not in IAD patients. DEGs enriched in cytokine-cytokine receptor interactions and gland secretion were considered to be associated with atopic march. Further investigations confirmed a marked IL17A upregulation in Chinese EAD with a positive relationship with total IgE level and AD severity. In addition, increased IL17A in AD patients with AR demonstrated a closer association with AR severity than IL4R. Moreover, AQP5 and CFTR were decreased in the lesions of AD patients with AR. The CFTR mRNA expression level was negatively associated with the skin IL17A level and AR severity. Conclusion Our research characterized marked Th17 activation in Chinese EAD patients, and altered expression of IL17A, IL4R, AQP5, and CFTR in AD patients with AR was associated with AR severity. It partially explained the phenotypic differences of AD subtypes and provided potential references for endotype-targeted therapy." @default.
• W3150218241 created "2021-04-13" @default.
• W3150218241 creator A5000808913 @default.
• W3150218241 creator A5005971604 @default.
• W3150218241 creator A5011176866 @default.
• W3150218241 creator A5012396478 @default.
• W3150218241 creator A5013279124 @default.
• W3150218241 creator A5015599512 @default.
• W3150218241 creator A5029705815 @default.
• W3150218241 creator A5032619855 @default.
• W3150218241 creator A5034813115 @default.
• W3150218241 creator A5048411940 @default.
• W3150218241 creator A5071602290 @default.
• W3150218241 creator A5079226794 @default.
• W3150218241 date "2021-04-01" @default.
• W3150218241 modified "2023-10-18" @default.
• W3150218241 title "RNA-Seq Identifies Marked Th17 Cell Activation and Altered CFTR Expression in Different Atopic Dermatitis Subtypes in Chinese Han Populations" @default.
• W3150218241 cites W1563589798 @default.
• W3150218241 cites W1965139821 @default.
• W3150218241 cites W1988242006 @default.
• W3150218241 cites W2005053801 @default.
• W3150218241 cites W2026526625 @default.
• W3150218241 cites W2035618305 @default.
• W3150218241 cites W2037222391 @default.
• W3150218241 cites W2085258093 @default.
• W3150218241 cites W2091063875 @default.
• W3150218241 cites W2179438025 @default.
• W3150218241 cites W2243398804 @default.
• W3150218241 cites W2339134557 @default.
• W3150218241 cites W2418549236 @default.
• W3150218241 cites W2624988788 @default.
• W3150218241 cites W2728647913 @default.
• W3150218241 cites W2751776779 @default.
• W3150218241 cites W2752670171 @default.
• W3150218241 cites W2765256236 @default.
• W3150218241 cites W2792361226 @default.
• W3150218241 cites W2810820884 @default.
• W3150218241 cites W2887508514 @default.
• W3150218241 cites W2891569672 @default.
• W3150218241 cites W2907756900 @default.
• W3150218241 cites W2944941526 @default.
• W3150218241 cites W2968185410 @default.
• W3150218241 cites W3006129194 @default.
• W3150218241 cites W3009713014 @default.
• W3150218241 cites W3017367295 @default.
• W3150218241 cites W3032505337 @default.
• W3150218241 cites W3048496213 @default.
• W3150218241 doi "https://doi.org/10.3389/fimmu.2021.628512" @default.
• W3150218241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8047326" @default.
• W3150218241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33868246" @default.
• W3150218241 hasPublicationYear "2021" @default.
• W3150218241 type Work @default.
• W3150218241 sameAs 3150218241 @default.
• W3150218241 citedByCount "14" @default.
• W3150218241 countsByYear W31502182412021 @default.
• W3150218241 countsByYear W31502182412022 @default.
• W3150218241 countsByYear W31502182412023 @default.
• W3150218241 crossrefType "journal-article" @default.
• W3150218241 hasAuthorship W3150218241A5000808913 @default.
• W3150218241 hasAuthorship W3150218241A5005971604 @default.
• W3150218241 hasAuthorship W3150218241A5011176866 @default.
• W3150218241 hasAuthorship W3150218241A5012396478 @default.
• W3150218241 hasAuthorship W3150218241A5013279124 @default.
• W3150218241 hasAuthorship W3150218241A5015599512 @default.
• W3150218241 hasAuthorship W3150218241A5029705815 @default.
• W3150218241 hasAuthorship W3150218241A5032619855 @default.
• W3150218241 hasAuthorship W3150218241A5034813115 @default.
• W3150218241 hasAuthorship W3150218241A5048411940 @default.
• W3150218241 hasAuthorship W3150218241A5071602290 @default.
• W3150218241 hasAuthorship W3150218241A5079226794 @default.
• W3150218241 hasBestOaLocation W31502182411 @default.
• W3150218241 hasConcept C104317684 @default.
• W3150218241 hasConcept C127716648 @default.
• W3150218241 hasConcept C141105273 @default.
• W3150218241 hasConcept C150194340 @default.
• W3150218241 hasConcept C152724338 @default.
• W3150218241 hasConcept C159654299 @default.
• W3150218241 hasConcept C162317418 @default.
• W3150218241 hasConcept C203014093 @default.
• W3150218241 hasConcept C207480886 @default.
• W3150218241 hasConcept C2778329239 @default.
• W3150218241 hasConcept C54355233 @default.
• W3150218241 hasConcept C71924100 @default.
• W3150218241 hasConcept C86803240 @default.
• W3150218241 hasConceptScore W3150218241C104317684 @default.
• W3150218241 hasConceptScore W3150218241C127716648 @default.
• W3150218241 hasConceptScore W3150218241C141105273 @default.
• W3150218241 hasConceptScore W3150218241C150194340 @default.
• W3150218241 hasConceptScore W3150218241C152724338 @default.
• W3150218241 hasConceptScore W3150218241C159654299 @default.
• W3150218241 hasConceptScore W3150218241C162317418 @default.
• W3150218241 hasConceptScore W3150218241C203014093 @default.
• W3150218241 hasConceptScore W3150218241C207480886 @default.
• W3150218241 hasConceptScore W3150218241C2778329239 @default.
• W3150218241 hasConceptScore W3150218241C54355233 @default.
• W3150218241 hasConceptScore W3150218241C71924100 @default.
• W3150218241 hasConceptScore W3150218241C86803240 @default.
• W3150218241 hasLocation W31502182411 @default.
• W3150218241 hasLocation W31502182412 @default.
• W3150218241 hasOpenAccess W3150218241 @default.

• next